LEVITEE LABS (LVTTF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 4 249 sessions, September 1, 2023 to September 4, 2024
- Largest daily move
- +100% close of September 20, 2023
- 1-year change
- -6.9% closing prices, September 1, 2023 to September 4, 2024
Company Description
LEVITEE LABS (OTC: LVTTF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $369.2K.
LVTTF has declined 6.9% over the past year. The last closing price was $0.0027.
This page collects what Stock Titan holds for LVTTF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LEVITEE LABS (LVTTF) closed at $0.0027 on September 4, 2024. Over the past 12 months, the price has lost 6.9%.
LVTTF Metrics & Rankings
Price returns through September 4, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
LEVITEE LABS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include private placement, partnership, management, acquisition. View all LVTTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LVTTF Company Profile & Sector Positioning
LEVITEE LABS (LVTTF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing LVTTF often look at related companies in the same sector, including CURASCIENTIFIC CORP (CSTF), LIVEWIRE ERGOGENICS INC (LVVV), DIGICANN VENTURES INC (AGFAF), GLOBAL HEMP GROUP INC (GBHPF), and GREATER CANNABIS CO (GCAN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LVTTF's relative position within its industry.